Keywords: Anticancer drugs / Platinum / DNA binding / Crown ethers / A2780 human ovarian cancerIn the search for novel platinum anticancer drugs, cisplatin derivatives and dinuclear platinum complexes containing oxa-aza crown ether and oxa-diaza crown ether ligands have been prepared. The cisplatin derivatives cis-[PtCl 2 (NH 3 )(1,4,7,10,13-pentaoxa-16-azacyclooctadecane-N)] (AO18) and cis-[PtCl 2 (NH 3 )(1,4,7,10-tetraoxa-13-azacyclopentadecane-N)] (AO15), and the dinuclear cationic platinum complexes [{trans-PtCl(NH 3 ) 2 } 2 (µ-1,4,10,13-tetraoxa-7,16-diazacyclooctadecane-N,NЈ)](NO 3 ) 2 (DAO18) and [{trans-PtCl(NH 3 ) 2 } 2 (µ-1,4,10-trioxa-7,13-diazacyclopentadecane-N,NЈ)](NO 3 ) 2 (DAO15) were investigated for their cytotoxic properties, cellular uptake and intracellular DNA binding in A2780 human ovarian cancer. The cisplatin derivative AO15 shows the highest cytotoxic activity, whereas the